TD ADSORBED SUSPENSION

দেশ: কানাডা

ভাষা: ইংরেজি

সূত্র: Health Canada

সক্রিয় উপাদান:

DIPHTHERIA TOXOID ADSORBED; TETANUS TOXOID ADSORBED

থেকে পাওয়া:

SANOFI PASTEUR LIMITED

এটিসি কোড:

J07AM51

INN (আন্তর্জাতিক নাম):

TETANUS TOXOID, COMB. WITH DIPHTHERIA TOXOID

ডোজ:

2LF; 5LF

ফার্মাসিউটিকাল ফর্ম:

SUSPENSION

রচনা:

DIPHTHERIA TOXOID ADSORBED 2LF; TETANUS TOXOID ADSORBED 5LF

প্রশাসন রুট:

INTRAMUSCULAR

প্যাকেজ ইউনিট:

5X0.5ML

প্রেসক্রিপশন টাইপ:

Schedule D

থেরাপিউটিক এলাকা:

TOXOIDS

পণ্য সারাংশ:

Active ingredient group (AIG) number: 0214427001; AHFS:

অনুমোদন অবস্থা:

APPROVED

অনুমোদন তারিখ:

2000-04-04

পণ্য বৈশিষ্ট্য

SANOFI PASTEUR PRODUCT MONOGRAPH
384, 420 TD ADSORBED
_Td ADSORBED (Tetanus and Diphtheria Toxoids Adsorbed) Page 1 of 22 _
PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
TD ADSORBED
TETANUS AND DIPHTHERIA TOXOIDS ADSORBED
Each 0.5 mL dose contains 5 Lf of Tetanus Toxoid and 2 Lf of
Diphtheria Toxoid
Suspension for injection
(For active immunization against Tetanus and Diphtheria)
ATC Code: J07AM51
SANOFI PASTEUR LIMITED
Toronto, Ontario, Canada
Date of Initial Authorization:
JUL 09, 1980
Date of Revision:
JUL 12, 2022
SUBMISSION CONTROL NUMBER: 261425
SANOFI PASTEUR PRODUCT MONOGRAPH
384, 420 TD ADSORBED
_Td ADSORBED (Tetanus and Diphtheria Toxoids Adsorbed) Page 2 of 22 _
TABLE OF CONTENTS
TABLE OF CONTENTS
................................................................................................................2
PART I: HEALTH PROFESSIONAL INFORMATION
.......................................................................4
1
INDICATIONS
................................................................................................................4
1.1
Pediatrics
............................................................................................................4
1.2
Geriatrics.............................................................................................................4
2
CONTRAINDICATIONS
...................................................................................................4
4
DOSAGE AND
ADMINISTRATION...................................................................................4
4.2
Recommended Dose and Dosage
Adjustment.......................................................4
4.4
Administration.....................................................................................................6
5
OVERDOSAGE
...............................................................................................................6
6
DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING
...................................6
7
WARNINGS AND PRECAUTIONS
................